StockNews.com Downgrades Edap Tms (NASDAQ:EDAP) to Sell

StockNews.com downgraded shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a sell rating in a research report report published on Friday morning.

Separately, HC Wainwright raised their target price on shares of Edap Tms from $16.00 to $19.00 and gave the company a buy rating in a research note on Monday, April 1st.

Edap Tms Stock Performance

EDAP opened at $7.15 on Friday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.30 and a current ratio of 2.84. The company has a market cap of $265.27 million, a PE ratio of -11.35 and a beta of 0.74. The stock has a 50-day moving average of $7.14 and a 200-day moving average of $6.26. Edap Tms has a 52-week low of $3.60 and a 52-week high of $12.23.

Edap Tms (NASDAQ:EDAP) last posted its earnings results on Wednesday, March 27th. The medical equipment provider reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.13). Edap Tms had a negative return on equity of 34.33% and a negative net margin of 35.03%. The company had revenue of $21.27 million during the quarter, compared to analyst estimates of $21.30 million. As a group, equities research analysts forecast that Edap Tms will post -0.31 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Edap Tms

Institutional investors and hedge funds have recently bought and sold shares of the stock. Milestone Investment Advisors LLC acquired a new stake in shares of Edap Tms during the 3rd quarter worth approximately $39,000. Summit Trail Advisors LLC bought a new stake in Edap Tms in the 3rd quarter valued at $77,000. Miracle Mile Advisors LLC acquired a new position in shares of Edap Tms in the 1st quarter valued at $136,000. Finally, Rock Springs Capital Management LP lifted its holdings in shares of Edap Tms by 14.6% during the 3rd quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock worth $9,547,000 after acquiring an additional 173,700 shares during the period. Institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.